Study to Evaluate Drug-Drug Interaction Between IDX719 and Simeprevir in Healthy Participants (MK-1894-004)
Status:
Completed
Trial end date:
2013-07-01
Target enrollment:
Participant gender:
Summary
The purpose of this 3-part study is to evaluate the potential impact of simeprevir and food
on pharmacokinetics (PK) of IDX719 in healthy participants. Part 1 will evaluate potential PK
interactions between IDX719 and simeprevir. Part 2 will evaluate the effect of food on the PK
of IDX719 in combination with simeprevir. Part 3 will evaluate the impact of high- versus
low-fat meals on the PK of IDX719.